Near-InfraRed Spectroscopy of Auricular Stimulation
University of Pittsburgh · NCT06825364
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- August 12, 2025
- Record last updated
- February 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a single-visit non-invasive study of healthy volunteer subjects. Brain activity will be measured with infra-red light sensors attached to a cap worn on the head, while both ears are gently stimulated with plastic filaments.
Being studied: auricular stimulation
Conditions: Healthy Male and Female Subjects; Healthy Volunteer Study
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Age of at least 18 years
Exclusion Criteria
- frequent or chronic pain requiring the use of pain-relieving medications more than twice per week, on average, in the last 3 months,
- history or symptoms of neuropathy,
- active lesions or skin disruptions to either ear,
- recent (\< 3 mo) illicit drug use,
- history of substance misuse/abuse,
- current or recent (\<1 month) opioid or marijuana use, and
- current regular use of psychoactive prescription medications
Recruiting US locations
University of Pittsburgh
Pittsburgh, PA 15213
Site contact: Keith Vogt, MD, PhD · vogtkm@upmc.edu
Study contacts (from the official record)
- Carly Riedmann, MPH · 412-623-4147 · riedmannca@upmc.edu
- Amy Monroe, MPH, MBA · 412-623-6382 · monroeal@upmc.edu
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only